Cytotoxicity of myeloperoxidase/nitrite-oxidized low-density lipoprotein toward endothelial cells is due to a high 7β-hydroxycholesterol to 7-ketocholesterol ratio

Free Radical Biology and Medicine

Volumn 41, Issue 7, 2006, Pages 1139-1150

  Steffen, Yvonne ^a   Wiswedel, Ingrid ^b   Peter, Daniela ^b   Schewe, Tankred ^a   Sies, Helmut ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cytotoxicity; Endothelial cells; Epicatechin; Flavonoids; HUVEC; Lipid peroxidation; Myeloperoxidase; Oxidative stress; oxLDL; Oxysterols

Indexed keywords

7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; APOCYNIN; COPPER; DNA FRAGMENT; EPICATECHIN; HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; NITRITE; OXYSTEROL; POLYPHENOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; ATHEROGENESIS; CYTOTOXICITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

CATECHIN; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYCHOLESTEROLS; KETOCHOLESTEROLS; LIPOPROTEINS, LDL; NITRITES; OXIDATION-REDUCTION; PEROXIDASE; UMBILICAL VEINS;

EID: 33748318022     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.06.027     Document Type: Article

References (67)

1. Esterbauer H., Gebicki J., Puhl H., and Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13 (1992) 341-390
2. Gaut J.P., and Heinecke J.W. Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. Trends Cardiovasc. Med. 11 (2001) 103-112
3. Albertini R., Moratti R., and De G. Luca, Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr. Mol. Med. 2 (2002) 579-592
4. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1478
5. Biasi F., Leonarduzzi G., Vizio B., Zanetti D., Sevanian A., Sottero B., Verde V., Zingaro B., Chiarpotto E., and Poli G. Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: implications for proatherogenic gene modulation. FASEB J. 18 (2004) 693-695 Epub 2004 Feb 20
6. Pirillo A., Zhu W., Roma P., Galli G., Caruso D., Pelegatta F., and Catapano A.L. Oxysterols from oxidized LDL are cytotoxic but fail to induce hsp70 expression in endothelial cells. FEBS Lett. 462 (1999) 113-116
7. Ziedén B., Kaminskas A., Kristenson M., Kucinskiene Z., Vessby B., Olsson A.G., and Diczfalusy U. Increased 7′-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 967-971
8. Yosunobu Y., Hajashi K., Shingu T., Yamagata T., Kajiyama G., and Kambe M. Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against low-density lipoprotein and oxysterols. Atherosclerosis 155 (2001) 445-453
9. Rimner A., Al Makdessi S., Sweidan H., Wischhusen J., Rabenstein B., Shatat K., and Mayer P. Spyridopoulos, I. Relevance and mechanism of oxysterol stereospecificity in coronary artery disease. Free Radic. Biol. Med. 38 (2005) 535-544
10. Gelissen I.C., Brown A.J., Mander E.L., Kritharides L., Dean R.T., and Jessup W. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J. Biol. Chem. 271 (1996) 17852-17860
11. Lamaire-Ewing S., Prunet C., Montange T., Vejux A., Berthier A., Bessède G., Corcos L., Gambert P., Néel D., and Lizard G. Comparison of the cytotoxic, prooxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol. Toxicol. 21 (2005) 97-114
12. Aupeix K., Weltin D., Mejia J.E., Christ M., Marchal J., Freyssinet J.M., and Bischoff P. Oxysterol-induced apoptosis in human monocytic cell lines. Immunobiology 194 (1995) 415-428
13. Podrez E.A., Abu-Saud H.M., and Hazen S.L. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic. Biol. Med. 28 (2000) 1717-1725
14. Schewe T., and Sies H. Myeloperoxidase-induced lipid peroxidation of LDL in the presence of nitrite. Protection by cocoa flavanols. BioFactors 24 (2005) 49-58
15. Daugherty A., Dunn J.L., Rateri D.L., and Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94 (1994) 437-444
16. Carr A.C., Myzak M.C., Stocker R., McCall M.R., and Frei B. Myeloperoxidase binds to low-density lipoprotein; potential implications for atherosclerosis. FEBS Lett. 487 (2000) 176-180
17. Podrez E.A., Schmitt D., Hoff H.F., and Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL in its atherogenic form in vitro. J. Clin. Invest. 103 (1999) 1547-1560
18. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., and Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272 (1997) 1433-1436
19. Podrez E.A., Febbraio M., Sheibani N., Schmitt D., Silverstein R.L., Hajjar D.P., Cohen P.A., Frazier W.A., Hoff H.F., and Hazen S.L. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105 (2000) 1095-1108
20. Kraemer T., Prakosay I., Date R.A., Sies H., and Schewe T. Oxidative modification of low-density lipoprotein: lipid peroxidation by myeloperoxidase in the presence of nitrite. Biol. Chem. 385 (2004) 809-918
21. Rodriguez J., Maloney R.E., Rassaf T., Bryan N.S., and Feelisch M. Chemical nature of nitric oxide storage forms in rat vascular tissues. Proc. Natl. Acad. Sci. USA 100 (2003) 336-341
22. Heiss C., Dejam A., Kleinbongard P., Schewe T., Sies H., and Kelm M. Vascular effects of cocoa rich in flavan-3-ols. JAMA 290 (2003) 1030-1031
23. Heiss C., Kleinbongard P., Dejam A., Perre S., Schroeter H., Sies H., and Kelm M. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J. Am. Coll. Cardiol. 46 (2005) 1276-1283
24. Engler M.B., Engler M.M., Chen C.Y., Malloy M.J., Browne A., Chiu E.Y., Kwak H.K., Milbury P., Paul S.M., Blumberg J., and Mietus-Snyder M.L. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J. Am. Coll. Nutr. 23 (2004) 197-204
25. Fisher N.D.L., Hughes M., Gerhard-Herman M., and Hollenberg N.K. Flavanol-rich cocoa induces nitric oxide-dependent vasodilation in healthy humans. J. Hypertens 21 (2003) 2281-2286
26. Schroeter H., Heiss C., Balzer J., Kleinbongard P., Keen C.L., Hollenberg N.K., Sies H., Kwik-Uribe C., Schmitz H.H., and Kelm M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA 103 (2006) 1024-1029
27. Buijsse B., Feskens E.J.M., Kok F.J., and Kromhout D. Cocoa intake, Blood pressure, and cardiovascular mortality. The Zutphen Elderly Study. Arch. Intern. Med. 166 (2006) 411-417
28. Schroeder P., Klotz L.O., Buchczyk D.P., Sadik C.D., Schewe T., and Sies H. Epicatechin selectively prevents nitration but not oxidation reactions of peroxynitrite. Biochem. Biophys. Res. Commun. 285 (2001) 782-787
29. Steffen Y., Schewe T., and Sies H. Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem. Biophys. Res. Commun. 331 (2005) 1277-1283
30. Kleinveld H.A., Hak-Lemmers H.L., Stalenhoef A.F., and Demacker P.N. Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin. Chem. 38 (1992) 2066-2072
31. Zhang H.F., Davis W.B., Chen X.S., Whisler R.L., and Cornwell D.G. Studies on oxidized low density lipoproteins. Controlled oxidation and a prostaglandin artifact. J. Lipid Res. 30 (1989) 141-148
32. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
33. Hodis H.N., Crawford D.W., and Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 89 (1991) 117-126
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application for proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
35. Kerr J.F.R., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
36. Boldin M.P., Mett I.L., Varfolomeev E.E., Chumakov I., Shemer-Avni Y., Camonis J.H., and Wallach D. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270 (1995) 7795-7798
37. 2 in cultured endothelial cells. Arch. Biochem. Biophys. 302 (1993) 348-355
38. Brown A.J., Leong S., Dean R.T., and Jessup W. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J. Lipid Res. 38 (1997) 1730-1745
39. Patel R.P., Diczfalusy U., Dzeletovic S., Wilson M.T., and Darley-Usmar V.M. Formation of oxysterols during oxidation of low-density lipoprotein by peroxynitrite, myoglobin and copper. J. Lipid Res. 37 (1996) 2361-2371
40. Heinloth A., Heermeier K., Raff U., Wanner C., and Galle J. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J. Am. Soc. Nephrol. 11 (2000) 1819-1825
41. Rueckschloss U., Galle J., Holtz J., Zerkowski H.R., and Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 104 (2001) 1767-1772
42. Riganti C., Costamagna C., Bosia A., and Ghigo D. The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress. Toxicol. Appl. Pharmacol. 212 (2006) 179-187
43. Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radic. Biol. Med. 14 (1993) 313-323
44. Schewe T. Molecular actions of ebselen-An antiinflammatory antioxidant. Gen. Pharmacol. 26 (1995) 1153-1169
45. Maiorino M., Roveri A., and Ursini F. Antioxidant effect of ebselen (PZ 51): peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity. Arch. Biochem. Biophys. 295 (1992) 404-409
46. Thomas J.P., Geiger P.G., and Girotti A.W. Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. J. Lipid Res. 34 (1993) 479-490
47. Christison J., Sies H., and Stocker R. Human blood cells support the reduction of low-density-lipoprotein-associated cholesteryl ester hydroperoxides by albumin-bound ebselen. Biochem.J. 304 (1994) 341-345
48. Furtmüller P.G., Burner U., Jantschko W., Regelsberger G., and Obinger C. Two-electron reduction and one-electron oxidation of organic hydroperoxides by human myeloperoxidase. FEBS Lett. 484 (2000) 139-143
49. Chang Y.H., Abdalla D.S.P., and Sevanian A. Characterization of cholesterol oxidation products formed by oxidative modification of low-density lipoprotein. Free Radic. Biol. Med. 23 (1997) 202-214
50. Zouaoui Boudjeltia K., Moguilevsky N., Legssyer I., Babar S., Guillaume M., Delree P., Vanhaeverbeek M., Brohee D., Ducobu J., and Remacle C. Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation. Biochem. Biophys. Res. Commun. 325 (2004) 434-438
51. van der Vliet A., Eiserich J.P., Halliwell B., and Cross C.E. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 272 (1997) 7617-7625
52. Brennan M.-L., Wu W., Fu X., Shen Z., Song W., Frost H., Vadseth C., Narine L., Lenkiewicz E., Borchers M.T., Lusis A.J., Lee J.J., Lee N.A., Abu-Soud H.M., Ischiropoulos H., and Hazen S.L. A tale of two controversies. Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 277 (2002) 17415-17427
53. Korytowski W., Bachowski G.J., and Girotti A.W. Chromatographic separation and electrochemical determination of cholesterol hydroperoxides generated by photodynamic action. Anal. Biochem. 197 (1991) 149-156
54. Korytowski W., Bachowski G.J., and Girotti A.W. Photoperoxidation of cholesterol in homogeneous solution, isolated membranes, and cells: comparison of the 5 alpha- and 6 beta-hydroperoxides as indicators of singlet oxygen intermediacy. Photochem. Photobiol. 56 (1992) 1-8
55. Abu-Soud H.M., and Hazen S.L. Nitric oxide is a physiological substrate for mammalian peroxidases. J. Biol. Chem. 275 (2000) 37524-37532
56. Eiserich J.P., Baldus S., Brennan M.-L., Ma W., Zhang C., Tousson A., Castro L., Lusis A.J., Nauseef W.M., White C.R., and Freeman B.A. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296 (2002) 2391-2394
57. Leonarduzzi G., Gamba P., Sottero B., Kadl A., Robbesyn F., Calogero R.A., Chiarpotto E., Leitinger N., Sevanian A., and Poli G. Oxysterol-induced up-regulation of MPC-1 expression and synthesis in macrophage cells. Free Radic. Biol. Med. 39 (2005) 1152-1161
58. Hayden J.M., Brachova L., Higgins K., Obermiller L., Sevanian A., Khandrika S., and Reaven P.D. Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J. Lipid Res. 43 (2002) 26-35
59. Shimozawa M., Naito Y., Manabe H., Uchiyama K., Kuroda M., Katada K., Yoshida N., and Yoshikawa T. 7-Ketocholesterol enhances the expression of adhesion molecules on human aortic endothelial cells by increasing the production of reactive oxygen species. Redox Rep. 9 (2004) 370-375
60. Yoshioka N., Adachi J., Ueno Y., and Yoshida K. Oxysterols increase in diabetic rats. Free Radic. Res. 39 (2005) 299-304
61. Schmitt D., Shen Z., Zhang R., Colles S.M., Wu W., Salomon R.G., Chen Y., Chisolm G.M., and Hazen S.L. Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum. Biochemistry 38 (1999) 16904-16915
62. Coffey M.D., Cole R.A., Colles S.M., and Chisolm G.M. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J. Clin. Invest. 96 (1995) 1866-1873
63. Colles S.M., Irwin K.C., and Chisolm G.M. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7beta-hydroperoxycholesterol. J. Lipid Res. 37 (1996) 2018-2028
64. Li W., Hellsten A., Xu L.-H., Zhuang D.-M., Jansson K., Brunk U.T., and Yuan X.-M. Foam cell death induced by 7β-hydroxycholesterol is mediated by labile iron-driven oxidative injury: mechanisms underlying induction of ferritin in human atheroma. Free Radic. Biol. Med. 39 (2005) 864-875
65. Kostyuk V.A., Kraemer T., Sies H., and Schewe T. Myeloperoxidase/nitrite-mediated lipid peroxidation of low-density lipoprotein as modulated by flavonoids. FEBS Lett. 537 (2003) 146-150
66. Jeong Y.-J., Choi Y.-J., Kwon H.-M., Kang S.-W., Park H.-S., Lee M., and Kang Y.-H. Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids. Br. J. Nutr. 93 (2005) 581-591
67. Ruiz E., Padilla E., Redondo S., Gordillo-Moscoso A., and Tejerina T. Kaempferol inhibits apoptosis in vascular smooth muscle induced by a component of oxidized LDL. Eur. J. Pharmacol. 529 (2006) 79-83